Sign In
Buy BMY
$54.72
+0.260 (+0.477%)
At Close: Jun 03, 2026
Element Squared LLC Acquires Shares of 48,420 Bristol Myers Squibb Company $BMY
05:04am, Saturday, 04'th Apr 2026
Element Squared LLC bought a new position in Bristol Myers Squibb Company (NYSE: BMY) in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The institutio
Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term
10:41am, Friday, 03'rd Apr 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Bristol Myers Squibb (NYSE:BMY) EVP David Elkins Sells 30,000 Shares
05:48am, Friday, 03'rd Apr 2026
Bristol Myers Squibb Company (NYSE: BMY - Get Free Report) EVP David Elkins sold 30,000 shares of the firm's stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price
BridgePort Financial Solutions LLC Buys 11,143 Shares of Bristol Myers Squibb Company $BMY
05:48am, Friday, 03'rd Apr 2026
BridgePort Financial Solutions LLC grew its stake in Bristol Myers Squibb Company (NYSE: BMY) by 228.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange
Bristol Myers Squibb Company $BMY Shares Sold by Compagnie Lombard Odier SCmA
05:08am, Friday, 03'rd Apr 2026
Compagnie Lombard Odier SCmA reduced its position in shares of Bristol Myers Squibb Company (NYSE: BMY) by 99.2% during the undefined quarter, according to the company in its most recent 13F filing wi
Janux Therapeutics Secures $35M Milestone Payment From BMY Deal
03:30pm, Thursday, 02'nd Apr 2026
JANX earns $35M milestone payment from Bristol Myers as TRACTr-based cancer candidate advances, signaling progress in its tumor-activated therapy platform.
Global pharma companies that have publicly announced Trump drug pricing agreements
02:59pm, Thursday, 02'nd Apr 2026
U.S. President Donald Trump secured agreements with 16 major pharmaceutical companies to bring U.S. prescription drug prices in line with those paid in other developed nations in exchange for three-ye
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
10:01am, Thursday, 02'nd Apr 2026
Bristol Myers (BMY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Ellsworth Advisors LLC Grows Position in Bristol Myers Squibb Company $BMY
05:14am, Thursday, 02'nd Apr 2026
Ellsworth Advisors LLC boosted its stake in shares of Bristol Myers Squibb Company (NYSE: BMY) by 9.4% in the undefined quarter, according to its most recent disclosure with the SEC. The institutional
Bristol Myers Squibb Sees Unusually High Options Volume (NYSE:BMY)
01:09am, Thursday, 02'nd Apr 2026
Bristol Myers Squibb Company (NYSE: BMY - Get Free Report) was the target of some unusual options trading on Wednesday. Stock traders purchased 66,895 call options on the stock. This is an increase of
Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Wednesday, 01'st Apr 2026
Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Foster & Motley Inc. Sells 12,772 Shares of Bristol Myers Squibb Company $BMY
04:05am, Wednesday, 01'st Apr 2026
Foster and Motley Inc. lowered its position in shares of Bristol Myers Squibb Company (NYSE: BMY) by 24.4% during the fourth quarter, according to its most recent filing with the Securities and Exchan
Bristol Myers Squibb (BMY) Ascends But Remains Behind Market: Some Facts to Note
06:46pm, Tuesday, 31'st Mar 2026
The latest trading day saw Bristol Myers Squibb (BMY) settling at $60.65, representing a +1.54% change from its previous close.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Tuesday, 31'st Mar 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Myeloma--Bristol Myers Squibb Evolves and Expands Standing in the Gaap to Advance More Equitable Care in Multiple Myeloma as Program Marks Ten Years.
